Natalie Maimon Rabinovich

2PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 29, 2025
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.

Alexander Yakobson, Ronen Brenner, Itamar Gothelf

|May 25, 2024
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status.

Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya

Pageof 1